Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
events
3
×
tc
battlefield
health
startups
ajay royan
bio
cancer
disease
disrupt
disrupt sf 2017
disrupt sf 2018
frederic moll
greentech
johnson & johnson
medicine
science
techcrunch disrupt sf 2019
What
unfortunately
affordable
ajay
amounts
auris
available
benefits
billion
cancer
cannabinoids
cb
ceo
come
company
consequence
critical
cultivation
day
despite
determining
disrupt
dozens
entrepreneurs
established
frederic
great
ground
grown
guesswork
hansen
having
household
important
include
inside
intensive
intuitive
inventors
investor
j
Language
Current search:
events
×
biotech
×
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@techcrunch.com
5 years ago
CB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordable
@techcrunch.com
6 years ago
Ourotech is taking the guesswork out of cancer treatment
